Clinical Trials Directory

Trials / Completed

CompletedNCT02038309

Persistent Platelet Reactivity in Acute Coronary Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
106 (actual)
Sponsor
Hopital Lariboisière · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study of persistent platelet reactivity during acute coronary syndrome. Patients are included at admission to the hospital. Platelet aggregation is evaluated by platelet function testing after blood sampling during hospitalization. No changes in treatment is planned.

Detailed description

Blood samples are performed on day 2 and 4 and collected with usual blood samples and analyzed by the laboratory. Maximal aggregation intensity and velocity are measured by light transmission aggregometry induced by arachidonic acid (AA) or adenosine diphosphate (ADP). Platelet function analyzer will be also used. No changes in treatment in response to the results is planned.

Conditions

Timeline

Start date
2013-01-01
Primary completion
2013-12-01
Completion
2015-12-01
First posted
2014-01-16
Last updated
2024-07-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02038309. Inclusion in this directory is not an endorsement.

Persistent Platelet Reactivity in Acute Coronary Syndrome (NCT02038309) · Clinical Trials Directory